OREM, Utah (PRWEB) February 14, 2018 — Accelerating the development of new digital cancer diagnostics in pathology is the aim of a new partnership between diagnostics pioneer Lumea and Southern…
Read More
OREM, Utah (PRWEB) February 14, 2018 — Accelerating the development of new digital cancer diagnostics in pathology is the aim of a new partnership between diagnostics pioneer Lumea and Southern…
*BxLink has not been approved by the FDA for digital primary diagnosis. Refer to CAP guidelines regarding the use of digital pathology technologies.